NeuroOne Medical Technologies C

Historical 13F Holders

Symbol
NMTC
CUSIP
64130M209
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 64130M209 since 12/18/2024, newest first.

Filer % of Class Filed
Sio Capital Management, LLC 13G/A Amendment 1 4.7% 11/12/2025
Event 9/30/2025
Bleichroeder LP 13G
8.0% 8/14/2025
Event 6/30/2025
Sio Capital Management, LLC 13G 7.1% 8/13/2025
Event 6/30/2025
Lytton Laurence W 13G/A Amendment 2 2.6% 5/15/2025
Event 3/31/2025
AWM Investment Company, Inc. 13G/A Amendment 4 4.8% 5/9/2025
Event 3/31/2025
Manchester Management Co LLC 13G/A Amendment 2
4.9% 2/14/2025
Event 12/31/2024
Merchant Adventure Fund, L.P. 13G/A Amendment 1 13.6% 2/4/2025
Event 12/31/2024
Nantahala Capital Management, LLC 13G/A Amendment 1
2.6% 11/14/2024
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 2 2.81 k $8.55 k
2026 Q1 32 11.8 M $9.14 M
2025 Q4 39 12.5 M $9.44 M
2025 Q3 36 14.4 M $12.8 M
2025 Q2 32 13.5 M $9.18 M
2025 Q1 21 1.93 M $1.64 M
2024 Q4 22 1.62 M $1.34 M
2024 Q3 23 2.42 M $2.40 M
2024 Q2 21 3.69 M $2.95 M
2024 Q1 20 2.85 M $3.42 M
2023 Q4 25 4.08 M $6.44 M
2023 Q3 22 2.62 M $2.33 M
2023 Q2 15 939 k $1.13 M
2023 Q1 16 963 k $1.55 M
2022 Q4 24 759 k $910 k
2022 Q3 12 410 k $686 k
2022 Q2 11 480 k $394 k
2022 Q1 12 707 k $777 k
2021 Q4 17 1.95 M $3.78 M
2021 Q3 10 251 k $989 k
2021 Q2 4 411 k $2.73 M